Clinical Trial Update: The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes [NA]

View source ↗

Summary

This update reports on a completed clinical trial evaluating GLP-1 receptor activation's effects on central reward and satiety in obesity and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2 | NA | Status: COMPLETED